High Insulin Prices Spur a Federal Lawsuit Against Three Pharmacy ...
WEB1 day ago · Pharmacy benefit managers, or PBMs, run prescription drug coverage for insurers, large employers and other clients. They set up formularies, or lists of covered drugs, and negotiate rebates off ...
Why PBMs, or pharmacy benefit managers, are the focus of new ... - NPR
WEBJul 7, 2023 · At least nine bills introduced in Congress take aim at pharmacy benefit managers, the powerful middlemen that channel prescription drugs to patients. Here's what the fuss is all about.
High insulin prices spur a federal lawsuit against three pharmacy ...
WEB1 day ago · The federal government is suing some big pharmacy benefit managers over a system of drug rebates that regulators say has made the price of insulin soar for diabetic patients. Three companies that process about 80% of prescriptions in the United States — Caremark, Express Scripts and OptumRx — have engaged in anticompetitive practices that ...
How PBMs Are Driving Up Prescription Drug Costs - The New York Times
WEBJun 21, 2024 · The three largest pharmacy benefit managers, or P.B.M.s, act as middlemen overseeing prescriptions for more than 200 million Americans.
Pharmacy benefit managers profit at expense of patients and small ... - CNN
WEBJul 9, 2024 · CNN — Pharmacy benefit managers, which negotiate the terms for prescription drug access for hundreds of millions of Americans, are racking up profits while squeezing patients and independent...
FTC Sues Pharmacy Benefit Managers for Inflating Insulin Prices
WEB1 day ago · Today, the Federal Trade Commission (FTC) announced that the organization filed legal action against the country’s three largest prescription drug benefit managers (PBMs)—Caremark Rx, Express Scripts and OptumRx—for engaging in anti-competitive and unfair practices that inflated the price of insulin drugs, blocked patients’ access to more affordable products and shifted the cost of ...
Explainer: Why are US pharmacy benefit managers under fire?
WEBWASHINGTON, July 9 (Reuters) - The U.S. Federal Trade Commission said on Tuesday in an interim report on its investigation into pharmacy benefit managers that healthcare consolidation has...
FTC Sues Prescription Drug Middlemen for Artificially Inflating …
WEB1 day ago · Today, the Federal Trade Commission brought action against the three largest prescription drug benefit managers (PBMs)—Caremark Rx, Express Scripts (ESI), and OptumRx—and their affiliated group purchasing organizations (GPOs) for engaging in anticompetitive and unfair rebating practices that have artificially inflated the list price of insulin drugs, impaired patients’ access to lower ...
PBMs, the Brokers Who Control Drug Prices, Finally ... - KFF Health News
WEBMay 11, 2023 · Drug manufacturers claim that exorbitant PBM demands for rebates force them to set high list prices to earn a profit. Independent pharmacists say PBMs are driving them out of business. Physicians blame them for …
Big Pharmacy-Benefit Managers Increase Drug Costs, FTC Says
WEBJul 9, 2024 · Firms that manage drug benefits, which promise to keep a lid on high drug costs, instead steer patients away from less expensive medicines and overcharge for cancer therapies, Federal Trade ...